Alder Biopharmaceuticals is a biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutic antibodies that have the potential to revolutionize current treatment practices. They have developed an innovative antibody platform that aims to identify antibodies with maximum efficacy, a quick response rate, and sustainable therapeutic benefits. The company is currently operating at a clinical stage, with plans to move forward in transforming healthcare.